Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
about
Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseasesDifferential effects of dry eye disorders on metabolomic profile by 1H nuclear magnetic resonance spectroscopyGoblet Cells Contribute to Ocular Surface Immune Tolerance-Implications for Dry Eye Disease.Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy.Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development.Effect of inflammation on lacrimal gland function.Nitric oxide and cGMP mediate alpha1D-adrenergic receptor-Stimulated protein secretion and p42/p44 MAPK activation in rat lacrimal gland.Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.Dry eye as a mucosal autoimmune disease.Meta-analysis of anti-muscarinic receptor type 3 antibodies for the diagnosis of Sjögren syndrome.Pharmacological cholinergic blockade stimulates inflammatory cytokine production and lymphocytic infiltration in the mouse lacrimal glandParasympathetic nervous system dysfunction in primary Sjögren's syndrome.Salivary gland scintigraphy in Sjögren's syndrome and patients with sicca symptoms but without Sjögren's syndrome: the psychological profiles and predictors for salivary gland dysfunction.Conjunctival epithelium improvement after systemic pilocarpine in patients with Sjogren's syndromePrimary Sjogrens syndrome is associated with impaired autonomic response to orthostasis and sympathetic failure.Sexual dimorphism in an animal model of Sjögren's syndrome: a potential role for Th17 cells.Autoimmunity at the ocular surface: pathogenesis and regulation.Deletion of interferon-γ delays onset and severity of dacryoadenitis in CD25KO mice.The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.Autonomic dysfunction in primary Sjogren's syndrome: a prospective cohort analysis of 154 Korean patients.Dry Eye Management: Targeting the Ocular Surface Microenvironment.Population-based study suggests an increased risk of Alzheimer'sdisease in Sjögren's syndrome.RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.A novel luminescence-based method for the detection of functionally active antibodies to muscarinic acetylcholine receptors of the M3 type (mAchR3) in patients' sera.Autoantibodies in Sjögren's Syndrome.
P2860
Q28241769-60BADC16-FDD7-4B63-B5C0-DEDD6896F77AQ30833462-5F6CEF24-0C8D-46FB-96C2-A67955C0BB0CQ33755012-ECD2C461-2E5C-41D5-88A5-CB525563ACC9Q34028408-25E70739-77C4-4328-A00E-7AC16D8BDCCDQ34313971-5FAEDA8F-4E53-4DA8-B0EA-6823D24F99B6Q34338027-EB86EFBF-BA46-4577-BDDC-5D4862A73EA5Q34375011-05F52D91-8C95-4190-B883-867C77861D21Q34476263-D2A23C55-CA08-4A2E-AAC7-5A24E8DB6ABBQ34647761-CEDFAB65-34F5-4CF5-BF1F-9FCA6F278691Q35023509-48E0FAB5-4542-4F30-82E7-6DF7C25CA5B1Q35027540-3C552263-954E-42AB-8A52-DA44AC0E5B39Q35177776-C479C225-CFD6-4BA9-BD4F-737CB98F0992Q35552123-530361D4-57CF-4C80-8B06-528D51575456Q35769293-199A77AC-38A2-4DA1-B609-F8DB65951BD7Q36429706-62D065D1-48BC-4F1E-8CEB-AEC746015D5CQ36506691-97408432-6775-4391-BFF1-DA75BDB14969Q36625074-121C01DD-3CBA-429B-B964-49B0C17DD94CQ36907644-6EBECD8C-8147-40C6-B349-7CE0001FCF6FQ37257746-C9C8F18C-5155-40BB-975A-1E22E0EBC560Q37559153-24E13E77-B8A9-41AD-ADE0-D466F2C6092AQ39404635-5FF133A7-2821-4DF3-9ABA-50BEEE840716Q47306169-69585143-B902-44B7-85B1-8767800B72BAQ49039960-4959B3CF-5345-4779-A53B-18B0E30550ECQ50459451-E473DD4A-AB83-47D2-822D-A2DF8CDF6FA4Q50926832-53E87FCC-94A2-4BF6-A629-1471F0904A5C
P2860
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
@ast
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
@en
type
label
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
@ast
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
@en
prefLabel
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
@ast
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome.
@en
P2093
P1476
Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome
@en
P2093
P304
P407
P577
2001-02-01T00:00:00Z